Navigation

polymyxin B/bacitracin ophthalmic (Ak-Poly-Bac, Polysporin Ophthalmic, Polycin)

 

Classes: Antibiotics, Ophthalmic Combos

Dosing and uses of Ak-Poly-Bac, Polysporin Ophthalmic (polymyxin-B-bacitracin-ophthalmic)

 

Adult dosage forms and strengths

polymyxin B / bacitracin ophthalmic

ointment

  • (polymyxin B 10,000units/bacitracin 500units)/g

 

Ophthalmic Infection

Often used in blepharitis, conjunctivitis, and post-operative prophylaxis

Apply thin 1/2 thin ribbon of ointment to conjunctival sac q3-4hr for 7-10 days

 

Pediatric dosage forms and strengths

polymyxin B / bacitracin ophthalmic

ointment

  • (polymyxin B 10,000units/bacitracin 500units)/g

 

Ophthalmic Infection

Often used in blepharitis, conjunctivitis, and post-operative prophylaxis

Apply thin 1/2 thin ribbon of ointment to conjunctival sac q3-4hr for 7-10 days

 

Ak-Poly-Bac, Polysporin Ophthalmic (polymyxin-B-bacitracin-ophthalmic) adverse (side) effects

<1%

Allergic contact dermatitis

Conjunctival erythema

Swelling

Itching

Burning

 

Warnings

Contraindications

Minor ocular irritation; hypersensitivity to polymixin or product components

 

Cautions

Ointment may blur vision

 

Pregnancy and lactation

Pregnancy category: C

Lactation: Excretion in breast milk unknown; use caution

 

Pregnancy categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

 

Pharmacology of Ak-Poly-Bac, Polysporin Ophthalmic (polymyxin-B-bacitracin-ophthalmic)

Mechanism of action

Inhibits bacterial cell wall synthesis by preventing the incorporation of amino acids and nucleotides into the cell walL